Choice Brokings executive director, Sumeet Bagadia, suggested purchasing two stocks amid the escalating geopolitical tensions ...

Despite NDMA-related cancer concerns and global withdrawals, Indian drug regulators have opted not to suspend Ranitidine, ...

Organised by the Hoad Hill Harriers in memory of the well-loved runner, the event will be back for 2025 on May 8.

The GSK share price took a dive in response to US import tariffs, but the company says it should be able to handle them. The ...

Glaxo (GSK) delivered earnings and revenue surprises of 4.63% and 0.85%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

LONDON (AP) — LONDON (AP) — GSK plc (GSK) on Wednesday reported first-quarter earnings of $2.04 billion. The London-based company said it had profit of $1 per share. Earnings, adjusted for one-time ...

It came as the FTSE 100 giant revealed a rise in sales as weakness in its vaccine division was offset by growth in speciality ...

FTSE 100 top-tenner GSK PLC (LSE:GSK, NYSE:GSK) has also reported earnings ahead of expectations, and kept full year guidance ...

As you would probably expect from such a well-known name connected to the healthcare industry, the goals for GSK for this new ...

Going forward, PTS and Appspace are providing ongoing service and support, with a team ensuring the systems perform at peak ...

Jonathan Rockoff is the Health Business editor at The Wall Street Journal, managing a team that reports on pharmaceutical and biotechnology companies, health insurers and hospitals. During the ...

Dana Cimilluca is former Wall Street bureau chief at The Wall Street Journal, where he managed a group of reporters and editors covering banks, hedge funds, private-equity firms, M&A and IPOs. He ...